A retrospective study of first-line combination chemotherapy in advanced colorectal cancer A Korean single-center experience.

被引:0
|
作者
Lee, S.
Park, J.
Park, S.
Kang, W.
Lim, H.
Park, Y.
Park, K.
Lee, J.
机构
[1] Dankook Univ Hosp, Cheonan, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
关键词
D O I
10.1200/jco.2011.29.4_suppl.623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
623
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience
    Lee, Soon Il
    Park, Se Hoon
    Lim, Do Hyoung
    Park, Keon Woo
    Lee, Jeeyun
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 96 - 101
  • [2] First-line chemotherapy with gemcitabine in advanced pancreatic cancer: a retrospective single-center analysis
    Magalhaes, H.
    Cassiano Neves, M.
    Fontes e Sousa, M.
    Machado, M.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Luis, M.
    Sales, C.
    ANNALS OF ONCOLOGY, 2015, 26
  • [3] Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study
    Woo, Sang Myung
    Lee, Woo Jin
    Han, Sung-Sik
    Park, Sang-Jae
    Kim, Tae Hyun
    Koh, Young Hwan
    Kim, Hyun Bum
    Hong, Eun Kyung
    Park, Joong-Won
    Kim, Chang-Min
    CHEMOTHERAPY, 2012, 58 (03) : 225 - 232
  • [4] Combination of cetuximab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience.
    Salek, T.
    Sebo, E.
    Mazalova, D.
    Chovanec, J.
    Stresko, M.
    Thomkova, A.
    Andrasina, I.
    Barilla, R.
    Hlavata, Z.
    Mego, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
    Yildiz, Ramazan
    Buyukberber, Suleyman
    Koca, Dogan
    Korai, Lokman
    Ciltas, Aydin
    Unal, Olcun Umit
    Gumus, Mahmut
    Ozdemir, Nuriye
    Dane, Faysal
    Berk, Veil
    Kaplan, Mehmet Ali
    Elkiran, Tamer
    Boruban, Melih Cern
    Coskun, Ugur
    Aydin, Dincer
    Uncu, Dogan
    Ozkan, Metin
    Isikdogan, Abdurrahman
    Benekli, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Comparison of the efficacy of gemcitabine with capecitabine and gemcitabine with erlotinib combination chemotherapy in recurrent or advanced pancreatic cancer as first-line treatment: Single-center experience
    Chun, S.
    Lee, M.
    Jeon, E.
    An, H.
    Hong, T.
    You, Y.
    Kim, D.
    Lee, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [7] A Multi-center Retrospective Study on First-line Chemotherapy for Advanced Pancreatic Cancer in China
    Cui, H.
    Deng, G.
    Yuan, J.
    Lou, C.
    Zhang, W.
    Zhou, A.
    Zhang, Y.
    Zhou, J.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1404 - 1404
  • [8] A Phase II Trial of Epirubicin, Oxaliplatin, and Capecitabine (EOX) as First-Line Chemotherapy in Advanced Gastric Cancer: A Chinese Single-Center Experience
    Xiang, Xiao Jun
    Qiu, Feng
    Xiong, Jian Ping
    Zhang, Ling
    Yu, Feng
    Feng, Miao
    Zhan, Zheng Yu
    CHEMOTHERAPY, 2010, 56 (03) : 171 - 177
  • [9] Combination of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: Slovakian experience
    Salek, T.
    Mego, M.
    Mardiak, J.
    Andrasina, I.
    Spanik, S.
    Malec, V.
    Barilla, R.
    Riedelova, K.
    Benedikty, A.
    Dammak, A.
    Porsok, S.
    Svabova, V.
    Chovanec, M.
    Cipkova, A.
    Usakova, V.
    Siskova, M.
    Jurisova, S.
    Dolinsky, J.
    Hlavata, Z.
    Andrezalova, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Second-line chemotherapy in advanced pancreatic cancer: A retrospective, single-center analysis
    Herrmann, T.
    Jaeger, D.
    Stremmel, W.
    Herrmann, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)